OLMESARTAN MEDOXOMIL
NDC 60290-009, OLMESARTAN MEDOXOMIL, tablet, from Umedica Laboratories USA Inc..
- Product NDC
- 60290-009
- Status
- Listed
- Labeler
- Umedica Laboratories USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207135
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60290-009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLMESARTAN MEDOXOMIL5 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60290-009-01 | 60290000901 | 30 TABLET in 1 BOTTLE (60290-009-01) |
| 60290-009-02 | 60290000902 | 90 TABLET in 1 BOTTLE (60290-009-02) |
| 60290-009-03 | 60290000903 | 10 TABLET in 1 BLISTER PACK (60290-009-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c49a7f23-2af0-4607-9f21-114970f8630d
Use it
Look up 60290-009 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60290-009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60290-009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.